European Journal of Molecular & Clinical Medicine

Aim: To correlate between the severity of diabetic peripheral polyneuropathy and glycosylated hemoglobin (HbA1C) levels.
Material and method: The present prospective observational study was conducted to evaluate the type 2 DM with peripheral neuropathy patients from December 2020 to August 2022. 100 subjects having age > 18 Years, patients diagnosed for DPN by clinically (DNS >=1)/ by electro diagnostic testing (in selected cases) were included in the study. HbA1c levels were assayed using Biochemical method. Severity of DPN Categorized By Neuropathy Disability Score (NDS).
Results: Hypertension and cardiovascular disease was revealed in 14.17% and 6.67% of the subjects respectively. NDS score viz. mild, moderate and severe deficits was found among 13%, 68% and 19% of the subjects respectively. Mean HbA1c level increases along with increase in NDS score i.e., higher the deficits, more is the HbA1c.
Conclusion: It can be concluded that increased HbA1c level indicative of chronic hyperglycemia, could significantly increase the risk and quantitatively reflect the severity of polyneuropathy in diabetic patients